Last Posted: May 22, 2017
Familial risk for lung cancer.
Kanwal Madiha et al. Oncology letters 2017 Feb (2) 535-542
Long and short noncoding RNAs in lung cancer precision medicine: Opportunities and challenges.
Tian Haihua et al. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017 Apr (4) 1010428317697578
Screening and Early Detection of Lung Cancer.
Eggert Julia A et al. Seminars in oncology nursing 2017 May (2) 129-140
Cost-Effectiveness of a Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.
Feller-Kopman David et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2017 May
Improving molecular testing and personalized medicine in non-small-cell lung cancer in Ontario.
Lim C et al. Current oncology (Toronto, Ont.) 2017 Apr 24(2) 103-110
Sample types applied for molecular diagnosis of therapeutic management of advanced non-small cell lung cancer in the precision medicine.
Han Yanxi et al. Clinical chemistry and laboratory medicine 2017 May
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.